ML20217Q237

From kanterella
Revision as of 00:58, 1 March 2021 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Concurs W/Final Rulemaking Package in Response to Petition for Rulemaking (PRM-35-7),if Enclosure B,Paragraph 2 Is Modified
ML20217Q237
Person / Time
Issue date: 09/12/1989
From: Bernero R
NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
To: Beckjord E
NRC OFFICE OF NUCLEAR REGULATORY RESEARCH (RES)
Shared Package
ML20217P754 List:
References
FOIA-98-86, RULE-PRM-35-7 NUDOCS 9804100351
Download: ML20217Q237 (2)


Text

_ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ,

Morris o

Bahadur

  • / onc 'o, UNITED STATES Telford 8' '% NUCLEAR REGULATORY COMMISSION 4sh 5 E WASHINGTON, O. C. 20555 file k-

,  ;;: ' ! %9 pt p , I 9.E9 MEM0PANDIN FOR: Eric S. Reckjord, Director Office of Nuclear Regulatory Research FROM: Robert M. Bernero, Director Office of Nuclear Materials Safety dnd Safeguards

SUBJECT:

REQUEST CONCURRENCE ON FINAL AMENDMENT TO 10 CFR 35.400 The Office of Nuclear Materials Safety and Safeguards concurs with the final rulemaking package in response to the petition for rulemaking (PRM-35-7), if Enclosure B, paragraph 2 is moaifiea to state that "The Food and Drug Administration pent.itted marketing of this Class II med cal device under Section 510(k) of the Fehral Food, Drug and Cosmetic Act as amended."

If you have any questions, please contact Donna-Beth Howe at Ext-20636.

},' L w Robert M. Bernero, Director Office of Nuclear Material Safety and Safeguaras

&q:

9804100351 980407 PDR FOIA I Il THOMPSON 98-86 PDR  ;

~

l u

ay? : t...

MEMORANDUM FOR: .Eric 5. Beckjora, Director Office of Nuclear Regulatory Research FROM:

Robert M. Bernero, Director Office of Nuclear Materials Safety and Safeguards

SUBJECT:

REQUEST CONCURRENCE ON FINAL AMENDMENT TO 10 CFR The Office of Nuclear Materials Safety and Safeguards concurs with the final rulemaking package in response to the petition for rulemaking (PRM-35-7), if Enclosure B, paragraph 2 is modified to state that "The Food and Drug Admini permittea marketing of this Class II medical device under Section 510(k) of the Federal Fooo, Drug and Cosmetic Act as amended."

If you have any questions, please contact Donna-Beth Howe at Ext-20636.

geti ,ud

  • WPA Robert N. Bernero, Of rector Office of Nuclear Material Safety and Safeguards '

DISTRIBUTION NMSS-89C0467 w/o incoming DBHowe IMAB R/F hMSS R/F NMSS Dir. Off. R/F IMNS Central Files JEGlenn NM-Elroy NRC File Center CJenkins GSjoblem MLamastra CEstep RECunningham SBaggett JFunches D/ Sh D/NMSS

  • See Previous Concurrence Motto RHBernero 9/g/89 09// 2./89
  • 0FC:IMAB *:IMAB *

":IMAB *:IMAB

...._____....w........___ ...........:_IMAB :DD/IMN5*:D/IMN NAME:DBHowe:ht:ga SLBag ____..____.________......._____.4.*.____

................________gett:NMcElroy:MLamastra:JEGlenn:GSjoblom:RECunningham DATE:09/06/89 :09/06/89:_.......________...________...__.......____ ....____

09/07/89: 09/06/89 :09/06/89 :09/09/89:09/09/89 OFFICIAL RECORD COPY a

i